semaglutide legal Novo Nordisk to protect US patients from unlawful sales of non-FDA approved 'semaglutide medicines' Ozempic Knock-Offs Contain Unsafe Substance

or exploring self-pay options including the NovoCare self-pay program (approximately $349/month for standard doses) or compounded semaglutide through a telehealth provider

Important safety information : Semaglutide has a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

As of May 2023, both Ozempic and Wegovy are included on the FDAs list of drug shortages

In these trials, 65% were White, 6% were Black or African American and 24% were Asian